Oncotype DX Genomic Prostate Score

Insurance Coverage & Financial Assistance

Genomic Health believes that everyone should have access to the information they need to make confident, informed decisions about their cancer treatments. That’s why Genomic Health created the Genomic Access Program (GAP), which helps eligible patients navigate insurance and other payment options for Oncotype DX GPS tests. Contact Customer Service by phone 866-ONCOTYPE (866-662-6897) or by email at customerservice@genomichealth.com.


Now favorable intermediate-risk prostate cancer patients are covered by Medicare


Your role in Medicare coverage

Medicare covers the Oncotype DX Genomic Prostate Score (GPS) test for eligible patients (NCCN very low, low, and favorable intermediate-risk disease). Providers must:

  • Enroll electronically to complete the Medicare-mandated certification and training.
  • Complete and submit reporting documents.

We assist your patients through the claims with their insurance company, including with your permission, help with appeals for any denial of coverage.

If your patient’s insurance covers the test, our patient assistance program will:

  • Work with the physician to get prior authorization from your insurance company (if required).
  • Bill insurance companies directly when possible.
  • Process the claim once the test is complete.
  • Assist in the appeal process if a claim is denied.

To get started with GAP, contact customer service at 866-ONCOTYPE (866-662-6897).

Financial assistance

Genomic Health offers financial assistance programs for eligible patients with financial hardship. These programs are based on financial eligibility. Contact Customer Service by phone at 866-ONCOTYPE (866-662-6897) or via email at customerservice@genomichealth.com for more information.

Do you need CTR training?

To qualify your patients for Medicare coverage, you
must be enrolled in Medicare's Certification and Training Registry. It's quick and easy.

Enroll Now

Stay in Touch

Have a specific question? Want to keep up with our latest news? We're here for you.

Contact Us
Making cancer care smarter.™